Skowerska Agnieszka, Wichniak Adam, Skalski Michał
III Klinika Psychiatryczna IPiN w Warszawie.
Psychiatr Pol. 2010 Sep-Oct;44(5):621-31.
In this study we investigated sleep and circadian rhythm, functioning and psychopathological symptoms in patients with schizophrenia. We looked for answers to the following questions: What percentage of patients with schizophrenia after a therapeutic process in the daily psychiatric ward suffers from insomnia and excessive daytime sleepiness? What factors influence the functioning of patients with schizophrenia.
23 patients and 23 healthy controls matched for age and sex (14 women, 9 men; mean age 40.5 +/- 13.66) were examined. All subjects filled out sleep diaries, underwent actigraphy for 7 days, and ratings with scales for the assessment of sleep quality, daytime sleepiness, general clinical state and the degree of improvement, presence and severity of psychopathological symptoms and depression, drug side effects.
Moderate insomnia was found in 6 (26%), severe insomnia in 2 (8%) patients. Four patients (17%) suffered from severe daytime sleepiness. Actigraphy showed a low activity level that had influence on the functioning of patients. The functioning of the patients was most negatively influenced by negative symptoms of schizophrenia and drug side effects. Older patients and those who were ill for a longer time presented more drug side effects and they were more depressive. The patients spent more time in bed and had longer sleep time than healthy controls. The patients presented highest activity at the time of therapeutic activities.
Despite improvement of psychopathological symptoms, many patients with schizophrenia still present low daytime activity and clinically significant insomnia and/or daytime sleepiness, which deteriorates their functioning.
在本研究中,我们调查了精神分裂症患者的睡眠和昼夜节律、功能以及精神病理症状。我们试图回答以下问题:在日常精神科病房接受治疗后的精神分裂症患者中,失眠和日间过度嗜睡的比例是多少?哪些因素影响精神分裂症患者的功能?
对23例患者和23名年龄及性别匹配的健康对照者(14名女性,9名男性;平均年龄40.5±13.66)进行了检查。所有受试者填写了睡眠日记,进行了7天的活动监测,并使用量表对睡眠质量、日间嗜睡、一般临床状态和改善程度、精神病理症状和抑郁的存在及严重程度、药物副作用进行了评分。
6例(26%)患者存在中度失眠,2例(8%)患者存在重度失眠。4例患者(17%)患有严重的日间嗜睡。活动监测显示活动水平较低,这对患者的功能有影响。患者的功能受精神分裂症的阴性症状和药物副作用的负面影响最大。年龄较大的患者和患病时间较长的患者出现更多的药物副作用,且更易抑郁。患者在床上花费的时间更多,睡眠时间比健康对照者更长。患者在治疗活动期间活动水平最高。
尽管精神病理症状有所改善,但许多精神分裂症患者仍表现出日间活动水平低以及临床上显著的失眠和/或日间嗜睡,这会使其功能恶化。